ArticleScientific reports2025

Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies.

Walaa H El-Maadawy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.